SCHEMBL4485980

SCHEMBL4485980

Cc1cc(=O)c(-c2ccc(-c3ccc(C=O)cc3)nc2)c(C)o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.40
CYP11B1 P15538 1/20 0.38
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 4/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MITF O75030 1/20 0.33
KLF5 Q13887 1/20 0.33
PTGS2 P35354 9/20 0.32
PTGER4 P35408 1/20 0.31
CASP3 P42574 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
CYP2A6 P11509 1/20 0.31
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13754677 0.85 PTGS2 (0.44) CYP11B1ALDH1A1HPGDPTGS2PTGER4
SCHEMBL4485765 0.84 MAPT (0.37) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL13761581 0.81 PTGS2 (0.48) BRD4KDM4EPTGS2CYP2A6MAPT
SCHEMBL3397603 0.81 KDM1A (0.40) CYP11B1KDM4EALDH1A1HPGDNPC1
SCHEMBL4478340 0.81 NOTUM (0.35) PTGS2PTGER4
SCHEMBL4485182 0.78 PTGS2 (0.44) PTGS2PTGER4
SCHEMBL4468273 0.77 ALDH1A1 (0.45) BRD4KDM4EALDH1A1HPGDNPC1
SCHEMBL4477921 0.76 DGAT1 (0.42) PTGER4
SCHEMBL4481069 0.75 TP53 (0.36) KDM4ESMN1; SMN2PTGS2MEN1POLB
SCHEMBL4471452 0.75 KDM1A (0.44) BRD4KDM4EALDH1A1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287461-A1 Pyridinone Derivatives Against Malaria G6PD, PNPO, PLPBP BRD4 2655/4885CYP11B1 95/4885KDM4E 1311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.